• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP
  • LOG IN

J&J's Du­a­to says 'not tar­iffs, but tax pol­i­cy' is best way to boost US man­u­fac­tur­ing

4 weeks ago
Pharma
Manufacturing

Con­gress should bar PBMs from own­ing phar­ma­cies, state at­tor­neys urge

4 weeks ago
Pharma

Phar­ma tar­iffs could leave lit­tle room to hide with sweep­ing probe un­der­way

4 weeks ago
Pharma
Manufacturing

Boehringer's bis­pe­cif­ic pact with Cue Bio­phar­ma; He­paRe­geniX rais­es €21.5M

4 weeks ago
News Briefing

Mur­al On­col­o­gy ends clin­i­cal de­vel­op­ment, lays off most work­ers

4 weeks ago
People
R&D

Sanofi’s Kymab-orig­i­nat­ed in­flam­ma­to­ry drug flunks mid-stage asth­ma tri­al

4 weeks ago
R&D

FDA clears clin­i­cal tri­al of gene-edit­ed pig liv­er used out­side of body

4 weeks ago
R&D

At­tovia col­lects an­oth­er $90M for I&I bi­o­log­ics in third fund­ing round in two years

4 weeks ago
Financing
Startups

J&J, phar­ma's earn­ings bell­wether, main­tains guid­ance as tar­iffs loom

4 weeks ago
Pharma

Ex­clu­sive: A small biotech will bring Roche's An­gel­man drug back to life

4 weeks ago
Startups
Deals

Mer­ck ex­plores po­ten­tial of oral pep­tides in deal with Aus­tri­an biotech

4 weeks ago
Deals
R&D

Sid­dhartha Mukher­jee’s cell ther­a­py start­up nar­rows fo­cus as staff shrinks

4 weeks ago
R&D
Cell/Gene Tx

Trump phar­ma tar­iffs inch clos­er as ad­min­is­tra­tion con­firms US trade probe

4 weeks ago
R&D
Pharma

Bris­tol My­ers says Camzyos fails Phase 3 study in ge­net­ic heart con­di­tion

4 weeks ago
R&D
Pharma

CDC vac­cine ad­vi­sors are set to meet this week af­ter two-month de­lay and scruti­ny from Kennedy

4 weeks ago
R&D
Pharma

BioN­Tech-backed ADC mak­er Du­al­i­ty­Bio plans IPO on Hong Kong ex­change

4 weeks ago
Financing
Startups

Ab­b­Vie and San­doz agree to drop court spat over Rin­voq patents

4 weeks ago
Pharma
FDA+

AMA asks Unit­ed­Health Group to re­lax cy­ber­at­tack loan re­coup­ment

4 weeks ago
Health Tech

FDA's union read­ies ne­go­ti­a­tions with HHS over some fired staff

4 weeks ago
FDA+

San­doz sues Am­gen over nine-year launch de­lay for En­brel biosim­i­lar

4 weeks ago
Pharma
FDA+

What's Pfiz­er's next move af­ter shelv­ing its oral obe­si­ty drug danuglipron?

4 weeks ago
Deals
Pharma

Pri­mate re­searchers cope with un­cer­tain­ty as NIH ap­peals for pay­ment cuts in court 

4 weeks ago
R&D
Pharma

Third Har­mon­ic to shut­ter; Fu­ture Pak once again tar­gets Ther­at­e­ch­nolo­gies

4 weeks ago
News Briefing

Iron­wood to look for al­ter­na­tive paths af­ter FDA asks for an­oth­er Phase 3

4 weeks ago
Pharma
FDA+
First page Previous page 891011121314 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times